Skip to main content

NextCure, Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

NXTC$6.27+17.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

NextCure, Inc.

Form 10-Q

For the Quarter Ended June 30, 2026

TABLE OF CONTENTS

​ · ​
​​Page
PART I. FINANCIAL INFORMATION
Item 1.Financial Statements1
​Condensed Balance Sheets as of June 30, 2026 (unaudited) and December 31, 20251
​Unaudited Condensed Statements of Operations and Comprehensive Loss for the Three and Six Months Ended June 30, 2026 and 20252
​Unaudited Condensed Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2026 and 20253
​Unaudited Condensed Statements of Cash Flows for the Six Months Ended June 30, 2026 and 20254
​Notes to Unaudited Condensed Financial Statements5
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3.Quantitative and Qualitative Disclosures about Market Risk30
Item 4.Controls and Procedures30
Part II. OTHER INFORMATION
Item 1.Legal Proceedings30
Item 1A.Risk Factors31
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds32
Item 3.Defaults Upon Senior Securities32
Item 4.Mine Safety Disclosures32
Item 5.Other Information32
Item 6.Exhibits33
SIGNATURES35

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.